Compare LITS & AXIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LITS | AXIL |
|---|---|---|
| Founded | 2000 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3M | 35.2M |
| IPO Year | 2003 | 2017 |
| Metric | LITS | AXIL |
|---|---|---|
| Price | $0.86 | $5.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 256.5K | 25.1K |
| Earning Date | 11-10-2026 | 10-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 13.81 | ★ 230.00 |
| EPS | ★ 0.48 | 0.05 |
| Revenue | N/A | ★ $30,847,570.00 |
| Revenue This Year | N/A | $12.27 |
| Revenue Next Year | N/A | $20.93 |
| P/E Ratio | ★ $1.75 | $103.80 |
| Revenue Growth | N/A | ★ 17.48 |
| 52 Week Low | $0.69 | $4.28 |
| 52 Week High | $2.00 | $9.86 |
| Indicator | LITS | AXIL |
|---|---|---|
| Relative Strength Index (RSI) | 34.75 | 37.20 |
| Support Level | $0.74 | N/A |
| Resistance Level | $1.08 | $6.35 |
| Average True Range (ATR) | 0.10 | 0.33 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 15.74 | 3.45 |
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor, and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients. The company operates in the segments: Digital Asset Treasury Strategy and Development of Pharmaceutical Products.
AXIL Brands Inc is engaged in the manufacturing, marketing, sale, and distribution of high tech hearing and audio enhancement and protection products, professional quality hair and skin care products, and the delivery of marketing services. The company has three operating segments: hearing enhancement and protection, hair and skin care and marketing services. The company generates majority of revenue from Hearing enhancement and protection segment. Hearing Enhancement and Protection Products are In-ear protection devices, Over-ear protection devices, and Accessories and others.